• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[迪戈斯病中的异常纤维蛋白溶解。3例研究]

[Abnormal fibrinolysis in Degos disease. A study of 3 cases].

作者信息

Caux F, Aractingi S, Scrobohaci M L, Fauvel-Lafève F, Arbeille B, Baccard M, Dubertret L

机构信息

Clinique des Maladies Cutanées, Hôpital Saint-Louis, Paris.

出版信息

Ann Dermatol Venereol. 1994;121(8):537-42.

PMID:7755309
Abstract

INTRODUCTION

Degos' disease is a rare dermatosis characterized by papular lesions with a porcelain-white central atrophy and histopathological aspect of wedge-shaped infarction necrosis and an endovasculitis in the dermis. Its pathogenesis is unknown but many abnormalities of haemostasis have been reported.

PATIENTS AND METHODS

Platelets functions, coagulation and fibrinolysis were estimated in three patients with Degos' disease. For one patient, direct immunoelectron microscopy using an antibody to von Willebrand factor was performed on lesional skin.

RESULTS

In all the patients, prolonged euglobulin lysis time, increased plasminogen activator (PA) and plasminogen activator inhibitor (PAI) activities before and after a venous occlusion test were detected and indicated an inhibition of fibrinolysis. Electron microscopy demonstrated in one case an increased number of Weibel-Palade bodies and a raised staining of von Willebrand factor in endothelial cells. Tests for coagulation and circulating anticoagulant were normal. Results of platelets adhesion showed decrease of adhesion in one case and increased adhesion in another. Platelets aggregation studies were normal in two cases and showed hyperactive spontaneous and induced aggregation in one case.

CONCLUSION

We showed an inhibition of fibrinolysis in three patients with Degos' disease. These abnormalities could induce a prethrombotic state. The release of PA and PAI from the endothelial cells into the blood stream and the modifications observed with electron microscopy may signify a primary lesion of endothelial cell of still unknown origin.

摘要

引言

迪戈斯病是一种罕见的皮肤病,其特征为丘疹性病变,中央有瓷白色萎缩,组织病理学表现为楔形梗死坏死以及真皮内血管炎。其发病机制尚不清楚,但已有许多止血异常的报道。

患者与方法

对三名迪戈斯病患者的血小板功能、凝血和纤溶进行了评估。对一名患者的皮损皮肤进行了使用抗血管性血友病因子抗体的直接免疫电子显微镜检查。

结果

所有患者均检测到优球蛋白溶解时间延长,静脉闭塞试验前后纤溶酶原激活物(PA)和纤溶酶原激活物抑制剂(PAI)活性增加,提示纤溶受到抑制。电子显微镜检查在一例中显示魏贝尔-帕拉德小体数量增加,内皮细胞中血管性血友病因子染色增强。凝血和循环抗凝剂检测正常。血小板黏附试验结果显示一例黏附降低,另一例黏附增加。两例血小板聚集研究正常,一例显示自发和诱导聚集亢进。

结论

我们发现三名迪戈斯病患者存在纤溶抑制。这些异常可能导致血栓前状态。PA和PAI从内皮细胞释放到血流中以及电子显微镜观察到的改变可能意味着内皮细胞的原发性病变,其起源尚不清楚。

相似文献

1
[Abnormal fibrinolysis in Degos disease. A study of 3 cases].[迪戈斯病中的异常纤维蛋白溶解。3例研究]
Ann Dermatol Venereol. 1994;121(8):537-42.
2
Endothelial cell activation in cutaneous vasculitis.皮肤血管炎中的内皮细胞活化
Clin Exp Dermatol. 1996 Jan;21(1):28-32.
3
Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.急性缺血性心脏病患者的纤维蛋白溶解。特别提及组织型纤溶酶原激活剂治疗对纤维蛋白溶解、凝血和补体途径的全身影响。
Dan Med Bull. 1993 Sep;40(4):383-408.
4
Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.青少年血液纤溶成分的年龄依赖性以及低剂量口服避孕药对青少年凝血和纤溶的影响。
Thromb Haemost. 1988 Dec 22;60(3):361-4.
5
Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology.不明原因早期复发性流产女性的血浆纤溶激活剂及其抑制剂
J Lab Clin Med. 1993 Nov;122(5):606-15.
6
Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.生长激素缺乏的成年人长期接受生长激素治疗可降低纤溶酶原激活物抑制剂-1和组织纤溶酶原激活物水平。
Thromb Haemost. 1996 Sep;76(3):422-8.
7
Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.某些骨髓增殖性综合征中的纤溶酶原激活剂(组织型纤溶酶原激活剂和尿激酶型纤溶酶原激活剂)及纤溶酶原激活剂抑制剂(PAI - 1和PAI - 2)
Med Sci Monit. 2000 Jul-Aug;6(4):684-91.
8
[Vascular function parameters in idiopathic and quartz-induced progressive scleroderma].[特发性和石英诱导性进行性硬皮病中的血管功能参数]
Hautarzt. 1993 Nov;44(11):717-22.
9
[Is Behçet's disease associated with characteristic abnormalities of coagulation and fibrinolysis? Apropos of 70 case reports].[白塞病与凝血及纤维蛋白溶解的特征性异常有关吗?基于70例病例报告]
J Mal Vasc. 1988;13(3):257-61.
10
Dyslipidemias and fibrinolysis.血脂异常与纤维蛋白溶解
Ital Heart J. 2002 Oct;3(10):579-86.